Authors: Stupp, R Bodmer, A Duvoisin, B Bauer, J Perey, L Bakr, M Ketterer, N Leyvraz, S

Citation: R. Stupp et al., Is cisplatin required for the treatment of non-small-cell lung cancer? Experience and preliminary results of a phase I/II trial with topotecan and vinorelbine, ONCOL-BASEL, 61, 2001, pp. 35-41

Authors: Dearden, CE Matutes, E Cazin, B Tjonnfjord, GE Parreira, A Nomdedeu, B Leoni, P Clark, FJ Radia, D Rassam, SMB Roques, T Ketterer, N Brito-Babapulle, V Dyer, MJS Catovsky, D

Citation: Ce. Dearden et al., High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H, BLOOD, 98(6), 2001, pp. 1721-1726

Authors: Ketterer, N Sonet, A Dumontet, C Moullet, I Thieblemont, C Espinouse, D Bouafia, F Coiffier, B Salles, G

Citation: N. Ketterer et al., Toxicities after peripheral blood progenitor cell transplantation for lymphoid malignancies: analysis of 300 cases in a single institution, BONE MAR TR, 23(12), 1999, pp. 1309-1315

Authors: Ketterer, N Salles, G

Citation: N. Ketterer et G. Salles, Infections following peripheral blood progenitor cell transplantation - Reply, AM J MED, 107(5), 1999, pp. 536-536

Authors: Ketterer, N Espinouse, D Chomarat, M Dumontet, C Moullet, I Rieux, C Neidhardt-Berard, EM Bouafia, F Coiffier, B Salles, G

Citation: N. Ketterer et al., Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: Etiology and potential risk factors, AM J MED, 106(2), 1999, pp. 191-197